February 18, 2013
If there's one device that's recently become a symbol for the promise -- and potential pitfalls -- of mobile health, it's AliveCor Heart Monitor, formerly known as the AliveCor iPhone ECG, which received FDA clearance for prescription use in December. Dr. Dave Albert, AliveCor's chief medical officer, outlined some next moves for the company recently in response to an online conversation about...
December 3, 2012
The FDA has granted a 510(K) Class II clearance to San Francisco-based AliveCor's iPhone-enabled heart monitor, which has been commonly known as the "iPhoneECG" since it first made an appearance at CES two years ago. The company announced the clearance as the mHealth Summit kicks off this week in the Washington DC area. AliveCor will begin pre-selling the $199 clinical-quality, ECG monitor,...
November 28, 2012
Behavior monitoring and analytics startup Ginger.io has raised $6.5 million dollars in its first round of funding, led by increasingly frequent digital health investor Khosla Ventures. Existing investors from the company's $1.7 million seed round in October 2011, True Ventures and Romulus Capital, also contributed.
Ginger.io, which absorbed mobile health startup Pipette earlier this year, offers...
August 27, 2012
AliveCor, originator of the widely praised iPhone ECG, is going to the dogs – and cats and horses.
San Francisco-based AliveCor, founded by Oklahoma City cardiologist and entrepreneur Dr. David Albert, as of this month is marketing an iPhone-based veterinary heart monitor to veterinary health professionals and pet owners. In fact, since the human product has not received Food and Drug...
July 2, 2012
The Nike+ fitness tracking system, likely the largest connected fitness network in the world, is going built-in and social. And, according to the sneaker giant, it's "Game On, World."
For the first time, Nike is embedding its fitness-tracking sensor into the insoles of its athletic shoes, starting with the Hyperdunk+ basketball shoe, the Lunar Hyperworkout+ trainer for women and LunarTR1+ trainer...
June 11, 2012
Khosla Ventures, the investment firm headed up by noted venture capitalist and Sun Microsystems co-founder Vinod Khosla, is increasingly making investments in mobile health startups. Khosla Ventures has made three investments in mobile health companies in as many months. In April we noted that Khosla had contributed to Misfit Wearables' $7.6 million second round of funding and just this morning...
June 11, 2012
San Francisco-based AliveCor, which has developed the iPhoneECG and iCard ECG, electrocardiogram peripheral devices for smartphones, has raised $10.5 million in its second round of funding. New investor Khosla Ventures led the latest round of funding along with return backer Burrill & Company. Existing investors Qualcomm Life Fund and Oklahoma Life Sciences Fund also contributed. AliveCor,...
February 1, 2012
By 2016 the number of patients monitored over mobile networks will hit 3 million, according to Juniper Research. The firm believes that increasing smartphone processing power along with new healthcare peripherals will cause an uptick in more patients using the smartphone as a home health hub. That shift will also lower the cost of remote patient monitoring since it will reduce the need for costly...
January 5, 2012
Apple's iPhone has been widely praised for its elegant design. Similarly, the much-heralded iPhone ECG from Dr. David Albert's AliveCor is simplistic in its form, easily bolting on to the back of the iconic smartphone.
A competing offering from Canadian mobile medical products developer Yoritex seems more diverse in its potential uses. But it appears to be clunkier when it comes to design,...
December 5, 2011
The future of mHealth is bright, according to West Wireless Health Institute vice chairman Eric Topol, who spoke this week at the opening keynote of the 2011 mHealth Summit. "This is a most momentous moment in medicine," he told the gathered audience. Topol's keynote discussion included current wireless medical products as well as future speculation that will leverage genomics with biosensor data...